Filing Details

Accession Number:
0001358403-16-000303
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-05 18:42:27
Reporting Period:
2016-12-05
Filing Date:
2016-12-05
Accepted Time:
2016-12-05 18:42:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358403 Bellicum Pharmaceuticals Inc BLCM Pharmaceutical Preparations (2834) 201450200
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627362 M. David Spencer C/O Bellicum Pharmaceuticals, Inc.
2130 W. Holcombe Blvd., Ste. 800
Houston TX 77030
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-05 5,000 $20.00 146,082 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 21, 2016 by the Reporting Person.